Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

The immune system works to maintain homeostasis throughout the body. Various cell types and immune mechanisms work in concert ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...

The research team, led by Professor Tu Wenwei (second right) and Professor Wang Weiping (second left), has made a ...

Aditxt (ADTX) announced that a recently completed study conducted by the Mayo Clinic further validates the preclinical findings of ADI-100, the ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

Synthetic NOTCH receptors offer tighter control over CAR expression, and engineered therapeutic genes are designed to activate ... and reduces markers of cell exhaustion. The T-charge platform ...

An Osaka Metropolitan University-led study demonstrated that Cdc42 (cell division cycle 42) plays a crucial role in the formation and maintenance of the morphological characteristics of quiescent ...